Lucid Diagnostics Prices $18M Underwritten Offering at $1.00/Share to Address Capital Needs
LUCD sits 20% above its 52-week low of $0.95 on elevated volume (2.3× avg).
Summary
Lucid Diagnostics priced an $18 million underwritten public offering of 18 million common shares at $1.00 each, securing crucial funding for working capital and general corporate purposes, with significant institutional investor support.
Key Events · Financing and Capital Events · LUCD
-
Underwritten Offering Priced
Lucid Diagnostics priced an underwritten public offering of 18,000,000 shares of common stock at $1.00 per share.
-
Gross Proceeds of $18 Million
The offering is expected to generate gross proceeds of $18,000,000 before deducting underwriting discounts and expenses.
-
Institutional Investor Anchors Offering
The offering is anchored by a $15 million investment from a fundamental institutional investor, with support from a large existing shareholder.
-
Funds for Working Capital
Net proceeds from the offering will be used for working capital and general corporate purposes, addressing the company's previously disclosed going concern warning.
Analysis · LUCD · Industrial Applications And Services
Lucid Diagnostics Inc. has priced an underwritten public offering of 18,000,000 shares of common stock at $1.00 per share, generating gross proceeds of $18 million. This offering, made under an existing shelf registration statement, finalizes the terms of a significant capital raise. The pricing represents a discount of approximately 12.16% compared to the current stock price of $1.1384. The company previously disclosed a going concern warning in its most recent 10-K, making this capital infusion critical for its operations and to extend its financial runway. A notable positive is the $15 million investment from a fundamental institutional investor, signaling confidence in the company's future despite the dilutive nature of the offering. The issuance of 18 million new shares represents approximately 10.6% dilution to existing shareholders.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LUCD was trading at $1.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $192.9M. The 52-week trading range was $0.95 to $1.70. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.